LVTX — LAVA Therapeutics NV Cashflow Statement
0.000.00%
Last trade - 00:00
- $71.77m
- -$17.49m
- $6.77m
- 34
- 14
- 86
- 41
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -9.69 | -15.5 | -45.2 | -31.7 | -41.7 |
Depreciation | |||||
Non-Cash Items | 0.192 | 0.962 | 5.15 | 0.807 | 4.27 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.621 | 4.73 | 10.8 | 34.1 | -2.83 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -8.62 | -9.31 | -28.6 | 4.04 | -39 |
Capital Expenditures | -0.762 | -0.502 | -0.764 | -0.587 | -0.73 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.03 | 0 | -42.8 | 9.93 | -16.9 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.792 | -0.502 | -43.5 | 9.35 | -17.6 |
Financing Cash Flow Items | 0 | 22 | 61.8 | — | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.18 | 19 | 151 | 0.283 | -0.571 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -8.66 | 8.48 | 75.1 | 9.46 | -56.1 |